![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 220651-94-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Ruplizumab REF: TM-T76825CAS: 220651-94-5 | 95% - 95% | 228.00 €~1,621.00 € | Wed 26 Feb 25 |
![]() | Ruplizumab REF: 3D-CLA1059CAS: 220651-94-5 | - - - | To inquire | Tue 08 Apr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ruplizumab
CAS:220651-94-5
PF-03732010 is a humanized antibody targeting P-calmodulin with antitumor and antimetastatic activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76825
1mg | 228.00 € | ||
5mg | 593.00 € | ||
10mg | 812.00 € | ||
25mg | 1,199.00 € | ||
50mg | 1,621.00 € |
Estimated delivery in United States, on Wednesday 26 Feb 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ruplizumab
CAS:220651-94-5
Humanized whole monoclonal antibody targeting CD154; designed to treat rheumatic diseases
Ref: 3D-CLA1059
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire |
Estimated delivery in United States, on Tuesday 8 Apr 2025